Ixabepilone development across the breast cancer continuum: a paradigm shift

por Ibrahim, Nuhad K
Publicado 2010

Ixabepilone: Overview of Effectiveness, Safety, and Tolerability in Metastatic Breast Cancer

por Ibrahim, Nuhad K.
Publicado en Front Oncol (2021)

Prognostic significance of equivocal HER2 results and clinical utility of alternative chromosome 17 genes in patients with invasive breast cancer: a cohort study

por Sneige, Nour, Hess, Kenneth R., Multani, Asha S., Gong, Yun, Ibrahim, Nuhad K.
Publicado en Cancer (2016)

Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation o...

por Weiss, Anna, Bashour, Sami I., Hess, Kenneth, Thompson, Alastair M., Ibrahim, Nuhad K.
Publicado en Breast Cancer Res (2018)

Complete Metabolic Response on Interim (18)F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Long‐Term Survival in Patients with Breast Cancer Underg...

por Chen, Suyun, Ibrahim, Nuhad K., Yan, Yuanqing, Wong, Stephen T., Wang, Hui, Wong, Franklin C.
Publicado en Oncologist (2017)

Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized Trial

por Ibrahim, Nuhad K., Murray, James L., Zhou, Dapeng, Mittendorf, Elizabeth A., Sample, Dory, Tautchin, Michael, Miles, David
Publicado 2013

Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases

por Alhalabi, Omar, Soomro, Zaid, Sun, Ryan, Hasanov, Elshad, Albittar, Aya, Tripathy, Debu, Valero, Vicente, Ibrahim, Nuhad K.
Publicado en NPJ Breast Cancer (2021)

Breast Cancer With Brain Metastases: Clinicopathologic Features, Survival, and Paired Biomarker Analysis

por Shen, Qi, Sahin, Aysegul A., Hess, Kenneth R., Suki, Dima, Aldape, Kenneth D., Sawaya, Raymond, Ibrahim, Nuhad K.
Publicado en Oncologist (2015)

BMET-23 ANG1005, A NOVEL BRAIN-PENETRANT PEPTIDE-TAXANE CONJUGATE, FOR THE TREATMENT OF CNS METASTASES FROM BREAST CANCER

por Kumthekar, Priya, Bates, Susan, Kesari, Santosh, Brenner, Andrew, Anders, Carey, Garcia, Agustin, Ibrahim, Nuhad, Tkaczuk, Katherine, Tang, Shou-Ching
Publicado en Neuro Oncol (2015)

Central nervous system miliary metastasis in breast cancer: a case series analysis and proposed identification criteria of a rare metastasis subtype

por Bashour, Sami I., Ibrahim, Nuhad K., Schomer, Donald F., Hess, Kenneth R., Gao, Chao, Tripathy, Debu, Fuller, Gregory N.
Publicado en Br J Cancer (2020)

QOLP-02. PATIENT-REPORTED OUTCOMES FOLLOWING PERTUZUMAB PLUS HIGH-DOSE TRASTUZUMAB IN PATIENTS WITH HER2-POSITIVE METASTATIC BREAST CANCER (MBC) AND CENTRAL NERVOUS SYSTEM (CNS) PR...

por Kumthekar, Priya, Sahebjam, Solmaz, Pegram, Mark, Ibrahim, Nuhad, Sussell, Jesse, Nicholas, Alan, Fung, Anita, Cheng, Anna, Lin, Nancy U
Publicado en Neuro Oncol (2020)

Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the Literature

por Abdayem, Pamela, Ghosn, Marwan, Valero, Vicente, Walters, Ronald, Arun, Banu, Murray, James L., Theriault, Richard, Frye, Debbie, Ibrahim, Nuhad K.
Publicado 2014

Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer

por Pegram, Mark D, Borges, Virginia F, Ibrahim, Nuhad, Fuloria, Jyotsna, Shapiro, Charles, Perez, Susan, Wang, Karen, Schaedli Stark, Franziska, Courtenay Luck, Nigel
Publicado 2009

Results of a phase Ib trial of combination immunotherapy with a CD8+ T cell eliciting vaccine and trastuzumab in breast cancer patients

por Clifton, G. Travis, Litton, Jennifer K., Arrington, Karen, Ponniah, Sathibalan, Ibrahim, Nuhad K., Gall, Victor, Alatrash, Gheath, Peoples, George E., Mittendorf, Elizabeth A.
Publicado en Ann Surg Oncol (2017)

Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma

por Delpech, Yann, Bashour, Sami I, Lousquy, Ruben, Rouzier, Roman, Hess, Kenneth, Coutant, Charles, Barranger, Emmanuel, Esteva, Francisco J, Ueno, Noato T, Pusztai, Lajos, Ibrahim, Nuhad K
Publicado en Br J Cancer (2015)

Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine

por Jackson, Doreen, Qiao, Na, Greene, Julia M, Hale, Diane, Berry, John, Trappey, Alfred, Vreeland, Timothy, Clifton, Guy, Ibrahim, Nuhad, Toms, Annie, Peoples, George E, Mittendorf, Elizabeth A
Publicado en J Immunother Cancer (2015)

Phase III Multicenter Clinical Trial of the Sialyl-TN (STn)-Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer

por Miles, David, Roché, Henri, Martin, Miguel, Perren, Timothy J., Cameron, David A., Glaspy, John, Dodwell, David, Parker, Joanne, Mayordomo, José, Tres, Alejandro, Murray, James Lee, Ibrahim, Nuhad K.
Publicado 2011

ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases

por Tripathy, Debu, Tolaney, Sara M, Seidman, Andrew D, Anders, Carey K, Ibrahim, Nuhad, Rugo, Hope S, Twelves, Chris, Dieras, Veronique, Müller, Volkmar, Tagliaferri, Mary, Hannah, Alison L, Cortés, Javier
Publicado en Future Oncol (2019)

Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer

por Singareeka Raghavendra, Akshara, Alameddine, Hala F., Andersen, Clark R., Selber, Jesse C., Brewster, Abenaa M., Barcenas, Carlos H., Caudle, Abigail S., Arun, Banu K., Tripathy, Debu, Ibrahim, Nuhad K.
Publicado en Cancers (Basel) (2021)

Immunologic mapping of glycomes: implications for cancer diagnosis and therapy

por Zhou, Dapeng, Levery, Steven B., Hsu, Fong-Fu, Wang, Peng G., Teneberg, Susann, Almeida, Igor C., Li, Yunsen, Xu, Huaxi, Wang, Lai-Xi, Xia, Chengfeng, Ibrahim, Nuhad K, Michael, Katja
Publicado 2011